Andrea Conti (A Conti)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatologic therapy

The British journal of dermatology

Advanced materials (Deerfield Beach, Fla.)

Azienda Ospedaliero-Universitaria di Modena

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Ospedaliero-Universitaria di Modena

Italy

MD :: Dermatology

Publications

Matteo Sensi, Rafael Furlan de Oliveira, Marcello Berto, Marina Palmieri, Emilio Ruini, Pietro Antonio Livio, Andrea Conti, Marcello Pinti, Carlo Salvarani, Andrea Cossarizza, Joan M Cabot, Jordi Ricart, Stefano Casalini, María Begoña González-García, Pablo Fanjul-Bolado, Carlo Augusto Bortolotti, Paolo Samorì, Fabio Biscarini
Reduced Graphene Oxide Electrolyte-Gated Transistor Immunosensor with Highly Selective Multiparametric Detection of Anti-Drug Antibodies. Advanced materials (Deerfield Beach, Fla.) (2023)
Francesco Bellinato, Paolo Gisondi, Anna Balato, Giacomo Caldarola, Edoardo Cammarata, Elena Campione, Andrea Carugno, Andrea Conti, Monica Corazza, Paolo Dapavo, Annunziata Dattola, Vito Di Lernia, Massimo Gasperini, Salvatore Panduri, Francesca Prignano, Francesca Satolli, Enzo Spisni, Giampiero Girolomoni
Awareness of obesity among patients with psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andrea Conti, Rossana Tiberio
Real-world experience on the efficacy and safety of apremilast in bio-naïve patients with moderate plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Francesco Messina, Francesca Peccerillo, Giulia Odorici, Andrea Conti, Stefano Piaserico
Efficacy and safety of guselkumab in two psoriatic patients with hepatitis B and C virus infection. Dermatologic therapy 35 (3) (2022)
Stefano Piaserico, Andrea Conti, Francesco Messina, Alberto Meneguzzo, Giulia Odorici, Francesco Bellinato, Paolo Gisondi
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (4) (2021)
Delia Colombo, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Marina Talamonti, Matteo Megna, Massimo Raspanti, Matteo Paolinelli, Katharina Hansel, Alessandra Narcisi, Andrea Conti, Clara De Simone, Marco Adriano Chessa, Alina De Rosa, Eugenio Provenzano, Michela Ortoncelli, Chiara Moltrasio, Rosaria Fidanza, Martina Burlando, Annalisa Tonini, Francesca Maria Gaiani, Lucia Simoni, Alessandra Ori, Martina Fiocchi, Emanuela Zagni
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study. Dermatologic therapy (2021)
Giulia Odorici, Sergio Di Nuzzo, Monica Corazza, Federico Bardazzi, Chiara Cortelazzi, Lidia Sacchelli, Andrea Conti
Phototherapy: The patients' point of view. Photodermatology, photoimmunology & photomedicine 37 (2) (2020)
Francesca Di Tullio, Giulia Odorici, Claudia Lasagni, Marco Alfonso Capobianco, Andrea Conti, Victor Desmond Mandel
Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis. Dermatologic therapy 33 (6) (2020)
Paolo Gisondi, Francesco Bellinato, Andrea Conti, P Dapavo, S Piaserico, C De Simone, Andrea Chiricozzi, Annunziata Dattola, P Malagoli, G Malara, A Campanati, M Burlando, Maria Esposito, L Gallo, Giampiero Girolomoni
Consensus on the place in therapy of TNF-α inhibitors in the treatment of patients with chronic plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (9) (2020)
Paolo Gisondi, S Piaserico, Andrea Conti, Luigi Naldi
Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (6) (2020)
Paolo Gisondi, C Virga, S Piaserico, A Meneguzzo, Giulia Odorici, Andrea Conti, G Girolomoni
Switching from one infliximab biosimilar (CT-P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis. The British journal of dermatology 183 (2) (2020)
Andrea Conti, C Lasagni, L Bigi, G Pellacani
Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (8) (2020)
Federica Filippi, Giulia Odorici, Andrea Conti, V Di Lernia, S Di Nuzzo, M A Chessa, M Corazza, Annalisa Patrizi, F Bardazzi
Biological therapy in psoriatic patients whishing fatherhood: a multi-centre italian experience in real life. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (9) (2020)
Paolo Gisondi, P Facheris, P Dapavo, S Piaserico, Andrea Conti, L Naldi, Simone Cazzaniga, P Malagoli, A Costanzo
The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience. The British journal of dermatology 183 (2) (2020)
Andrea Conti, F Peccerillo, P Amerio, Anna Balato, F Bardazzi, L Bianchi, M Burlando, S P Cannavò, Andrea Chiricozzi, P Dapavo, C De Simone, M C Fargnoli, A Gambardella, Paolo Gisondi, P Malagoli, G Malara, C Mugheddu, A M Offidani, S Piaserico, Francesca Prignano, L Stingeni, G Pellacani
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience. The British journal of dermatology 180 (6) (2019)
Giulia Odorici, C Lasagni, L Bigi, G Pellacani, Andrea Conti
A real-life experience of psoriatic patients with history of cancer treated with biological drugs. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (12) (2019)

Andrea Conti.css-eqlu8i{font-size:small;padding-left:4px;} (A Conti)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrea Conti (A Conti)